Last reviewed · How we verify
NCT03873194
Meditation as Complementary Treatment for Chronic Hypertension in Pregnancy
NA trial testing Meditation in Hypertension, Pregnancy-Induced in 47 participants. Completed in 30 December 2021.
15 December 2021
Quick facts
| Lead sponsor | University of Sao Paulo General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 15 April 2019 |
| Primary completion | 15 December 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Meditation
- conventional treatment — full drug profile →
Conditions studied
- Hypertension, Pregnancy-Induced — all drugs for Hypertension, Pregnancy-Induced →
- Hypertension in Pregnancy — all drugs for Hypertension in Pregnancy →
- Hypertension — all drugs for Hypertension →
Sponsor
University of Sao Paulo General Hospital
Who can join
Adults 21 to 50, female only, with Hypertension, Pregnancy-Induced or Hypertension in Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pregnancy relates to arterial hypertension; it is an aggravating factor for pre-existing chronic arterial hypertension or a trigger for preeclampsia in normotensive women. The gestational hypertensive disease is managed conventionally with the pregnant woman's hospitalization and/or the use of antihypertensive medications. Nevertheless, this treatment may present some risks. The investigators seek to determine whether the intervention compared to the control can reduce the increase in blood pressure that pregnant women in the transition from the 2nd to the 3rd trimester.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03873194
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Meditation
Trials testing the same drug.
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
- NCT07310992 — Effect of Meditation as an Adjunct to Cardiac Rehabilitation · NA · not yet recruiting
- NCT07176013 — Immersive Virtual Reality Meditation in Voice Therapy · NA · enrolling by invitation
- NCT06866288 — Belongingness in Nursing Through Mindfulness - BEING Mindful: A Pilot Study · NA · completed
Other recruiting trials for Hypertension, Pregnancy-Induced
Currently open trials in the same condition.
- NCT06220721 — Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia · NA · recruiting
- NCT05655936 — Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial · NA · recruiting
- NCT07361679 — LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention · Phase 4 · recruiting
- NCT04012151 — Arm and Finger Measurement for Blood Pressure Surveillance · active not recruiting
Other University of Sao Paulo General Hospital trials
Trials by the same sponsor.
- NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
- NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
- NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
- NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03873194 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
- Last refreshed: 24 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03873194.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing